Clinical Trials Logo

Cancer, Thyroid clinical trials

View clinical trials related to Cancer, Thyroid.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT06458036 Not yet recruiting - Cancer Clinical Trials

Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE)

RAISE
Start date: August 1, 2024
Phase: Phase 2
Study type: Interventional

Papillary thyroid cancer (PTC) is the most common form of differentiated thyroid cancer (DTC). The traditional first line treatment for patients with advanced DTC after surgical resection is radioactive iodine (RAI) therapy. However, less than a quarter of patients with lung metastases will achieve a complete response to RAI therapy, and this therapy carries the risk of pulmonary fibrosis and an increasingly recognized risk of secondary malignancies.